Tenaya Therapeutics Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -124.1% | – | – | – | – | – | – | – | – | -8,548.4% | -2,052.8% | -5,360.2% | |
| – | 12.3% | – | – | – | – | – | – | – | – | 783.6% | 311.8% | 665.5% | |
| – | 22.4% | – | – | – | – | – | – | – | – | 976.0% | 351.1% | 881.8% | |
| – | -3.8% | – | – | – | – | – | – | – | – | -2,036.9% | 741.3% | 270.9% | |
| – | 2.2% | – | – | – | – | – | – | – | – | 4.9% | 15.3% | 20.5% | |
| – | -84.5% | – | – | – | – | – | – | – | – | -4.9% | -15.3% | 645.1% | |
| – | 2.1% | – | – | – | – | – | – | – | – | -184.4% | 44.5% | 4,397.1% | |
| – | -206.5% | – | – | – | – | – | – | – | – | -8,737.8% | -2,023.6% | -318.1% | |
| – | -126.3% | – | – | – | – | – | – | – | – | -8,553.3% | -2,068.1% | -5,380.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.